Table 2.
Serum tests for the LGcombo-treated mice
| Testa | Control | LGcombo | P valueb | Indication |
|---|---|---|---|---|
| Alanine aminotransferase, U/l | 40.3 ± 23.8 | 31.4 ± 7.5 | 0.292 | |
| Aspartate aminotransferase, U/l | 109.1 ± 57.9 | 90.8 ± 26.4 | 0.397 | |
| Alkaline phosphatase, U/l | 81.9 ± 33.4 | 83.2 ± 16.1 | 0.929 | |
| Blood urea nitrogen, mg/dl | 19.6 ± 1.1 | 16.5 ± 1.3 | 0.003 | Liver injury; reduced albumin secretion |
| Cholesterol, mg/dl | 161.1 ± 42.6 | 155.0 ± 24.2 | 0.739 | |
| Creatinine, mg/dl | 0.12 ± 0.03 | 0.14 ± 0.02 | 0.076 | |
| High density lipoprotein, mg/dl | 156.3 ± 33.6 | 150.6 ± 22.3 | 0.72 | |
| Low density lipoprotein, mg/dl | 16.7 ± 5.6 | 11.9 ± 3.3 | 0.054 | |
| Total bilirubin, mg/dl | 0.06 ± 0.02 | 0.12 ± 0.02 | 0.001 | Hemolysis; jaundice |
| Total protein, g/dl | 5.7 ± 0.4 | 5.3 ± 0.1 | 0.046 | Liver injury; reduced albumin secretion |
| Triglyceride, mg/dl | 77.8 ± 20.6 | 73.0 ± 38.3 | 0.765 | |
| Glucose, mg/dl (non-fasting) | 183.3 ± 37.1 | 142.1 ± 22.4 | 0.083 |
aBlood glucose levels were measured with the FreeStyle Lite Blood Glucose Monitoring System (Abbot Laboratories). The other blood tests were performed by the Comparative Pathology Laboratory, University of California, Davis
bCalculated using t-tests